Wird geladen...

Primaquine in vivax malaria: an update and review on management issues

Primaquine was officially licensed as an anti-malarial drug by the FDA in 1952. It has remained the only FDA licensed drug capable of clearing the intra-hepatic schizonts and hypnozoites of Plasmodium vivax. This update and review focuses on five major aspects of primaquine use in treatment of vivax...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Fernando, Deepika, Rodrigo, Chaturaka, Rajapakse, Senaka
Format: Artigo
Sprache:Inglês
Veröffentlicht: BioMed Central 2011
Schlagworte:
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC3306765/
https://ncbi.nlm.nih.gov/pubmed/22152065
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1475-2875-10-351
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!